Carrie Dougherty1. 1. Department of Neurology, MedStar Georgetown University Hospital, Hospital, 3800 Reservoir Road NW, 7-PHC, Washington, DC, 20007, USA. Carrie.O.Dougherty@gunet.georgetown.edu.
Abstract
PURPOSE OF REVIEW: Indomethacin is an important medication in the headache medicine toolbox given its utility for both of the diagnosis and treatment of several primary headache disorders. Despite its prevalence in earlier rheumatologic studies, the possibility of drug-induced headache is a not commonly discussed in headache literature. RECENT FINDINGS: Herein, we describe a case of drug-induced headache after indomethacin trial for the treatment of an undifferentiated trigeminal autonomic cephalgia. Recognition of indomethacin-induced headache has important implications for patient education and interpreting the response to indomethacin when used both as a therapeutic and as a diagnostic tool.
PURPOSE OF REVIEW: Indomethacin is an important medication in the headache medicine toolbox given its utility for both of the diagnosis and treatment of several primary headache disorders. Despite its prevalence in earlier rheumatologic studies, the possibility of drug-induced headache is a not commonly discussed in headache literature. RECENT FINDINGS: Herein, we describe a case of drug-induced headache after indomethacin trial for the treatment of an undifferentiated trigeminal autonomic cephalgia. Recognition of indomethacin-induced headache has important implications for patient education and interpreting the response to indomethacin when used both as a therapeutic and as a diagnostic tool.
Authors: Zsolt Hepp; David W Dodick; Sepideh F Varon; Patrick Gillard; Ryan N Hansen; Emily B Devine Journal: Cephalalgia Date: 2014-08-27 Impact factor: 6.292